# ERNEXA THERAPEUTICS INC (ERNAW)

> Institutional ownership reported to the SEC as of Q2 2026, from Form 13F filings. Source: https://holderbook.com/stocks/ERNAW/

- Reporting holders: 6
- Reported value: $202.3K
- Shares held by institutions: 2,836,819 of 1,632,411 outstanding
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Bleichroeder LP](https://holderbook.com/funds/1781002-bleichroeder-lp/) | $142.6K | 2,000,000 | 0.0% | 2 |
| [HEIGHTS CAPITAL MANAGEMENT, INC](https://holderbook.com/funds/1081698-heights-capital-management-inc/) | $28.5K | 400,000 | 0.0% | 2 |
| [ARMISTICE CAPITAL, LLC](https://holderbook.com/funds/1601086-armistice-capital-llc/) | $11.4K | 160,000 | 0.0% | 2 |
| [Clear Street Group Inc.](https://holderbook.com/funds/1881567-clear-street-group-inc/) | $10.7K | 149,499 | 0.0% | 2 |
| [Warberg Asset Management LLC](https://holderbook.com/funds/1597506-warberg-asset-management-llc/) | $5.0K | 69,430 | 0.0% | 2 |
| [SUSQUEHANNA INTERNATIONAL GROUP, LLP](https://holderbook.com/funds/1446194-susquehanna-international-group-llp/) | $4.1K | 57,890 | 0.0% | 1 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q2 2026 | 6 | $202.3K |
| Q1 2026 | 5 | $195.3K |
| Q3 2022 | 1 | $11.0K |
| Q2 2022 | 1 | $6.0K |
| Q1 2022 | 2 | $64.0K |
| Q4 2021 | 2 | $156.0K |
| Q3 2021 | 2 | $1.6M |
| Q2 2021 | 2 | $2.1M |